Hotline:
+ 49 (0) 2204 2918806

Market studies for category Obesity

Items 1 to 10 of 36 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  1. Net price*
    Year
  2. $3,495.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Velneperit (Obesity) - Forecast and Market Analysis to 2022

    GlobalData
    68 pages
    After a more than decade-long dormancy, the obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molecular
    Englisch | Zukunftsanalyse | SKU: 402255
  3. $9,995.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: Obesity - Global Drug Forecast and Market Analysis to 2022

    GlobalData
    542 pages
    After a more than decade long dormancy, the Obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molecular
    Englisch | Zukunftsanalyse | SKU: 401812
  4. $2,500.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Gaucher's Disease Type I Global Clinical Trials Review, H1, 2014

    GlobalData
    88 pages
    GlobalData's clinical trial report, “Gaucher's Disease Type I Global Clinical Trials Review, H1, 2014" provides data on the Gaucher’s Disease Type I clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gaucher’s Disease Type I. It includes an overview of the trial numbers an
    Englisch | Zukunftsanalyse | SKU: 403049
  5. $4,995.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: Obesity - Spain Drug Forecast and Market Analysis to 2022

    GlobalData
    111 pages
    After a more than decade long dormancy, the Obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molecular
    Englisch | Zukunftsanalyse | SKU: 401826
  6. $3,495.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Qsymia (Obesity) - Forecast and Market Analysis to 2022

    GlobalData
    52 pages
    After a more than decade-long dormancy, the obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molecular
    Englisch | Marktstudie | SKU: 402035
  7. $3,495.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Xenical (Obesity) - Forecast and Market Analysis to 2022

    GlobalData
    49 pages
    After a more than decade-long dormancy, the obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molecular
    Englisch | Marktstudie | SKU: 402040
  8. $3,495.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Qsymia (Obesity) - Forecast and Market Analysis to 2022

    GlobalData
    52 pages
    After a more than decade-long dormancy, the obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molecular
    Englisch | Zukunftsanalyse | SKU: 402248
  9. $3,495.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Xenical (Obesity) - Forecast and Market Analysis to 2022

    GlobalData
    49 pages
    After a more than decade-long dormancy, the obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molecular
    Englisch | Zukunftsanalyse | SKU: 402253
  10. $5,995.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    OpportunityAnalyzer: Gout - Opportunity Analysis and Forecast to 2018

    GlobalData
    181 pages
    GlobalData estimates the 2013 sales for gout at approximately $989m across the 6MM covered in this report. The acute gout segment of the market will double in size over the forecast period, reaching $337m in 2018 at a CAGR of 15%. The chronic gout market, which encompasses urate-lowering and prophylactic anti-inflammatory therapies, will
    Englisch | Zukunftsanalyse | SKU: 403047
  11. $4,995.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: Obesity - Germany Drug Forecast and Market Analysis to 2022

    GlobalData
    116 pages
    After a more than decade long dormancy, the Obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molecular
    Englisch | Zukunftsanalyse | SKU: 401824

Items 1 to 10 of 36 total

  1. 1
  2. | 2
  3. | 3
  4. | 4